A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Eli Lilly and Company
Start Date
October 15, 2016
End Date
November 30, 2019
Administered By
School of Medicine
Awarded By
Eli Lilly and Company
Start Date
October 15, 2016
End Date
November 30, 2019